Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson Disease
Open Access
- 1 May 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 70 (5) , 565-570
Abstract
Parkinson disease (PD) is a chronic neurodegenerative disease whose burden is increasing rapidly in the United States and around the world. However, access to care is limited by distance, disability, and the distribution of doctors.1 Among US Medicare beneficiaries with PD, more than 40% have not seen a neurologist.2Keywords
This publication has 30 references indexed in Scilit:
- Systematic review of teleneurology: methodologyFrontiers in Neurology, 2012
- Comparison of office‐based versus home web‐based clinical assessments for Parkinson's diseaseMovement Disorders, 2011
- Neurologist care in Parkinson diseaseNeurology, 2011
- Group patient visits for Parkinson diseaseNeurology, 2011
- A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groupsMovement Disorders, 2010
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trialThe Lancet Neurology, 2010
- Treatment disparities in Parkinson's diseaseAnnals of Neurology, 2009
- Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective studyThe Lancet Neurology, 2008
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995